Investors

THRU PHARMA LLC, d/b/a PharmaCline™, is a life science company specializing in pathogen genomics, bioinformatics and therapeutics that was organized as a limited liability company in the State of Delaware on December 6, 2010. The Company’s offices are located in Sioux Falls, South Dakota. The Company is a member of leading industry and patient-centered associations and organizations. The technologies and products offered are designed to meet unmet needs in these growth markets, with a heavy emphasis in wound care.

The Company’s leading product, Diabecline® antibiotic, has received multiple awards for Best New Pharmaceutical during 2012. In April 2012, receipt of the Edison Award (Bronze) recognized the innovation of the product at a ceremony in conjunction with the New York Academy of Sciences. Then in September 2012, the product received the American Business Awards Silver medal for Best New Pharmaceutical at a ceremony in San Francisco.